Poteligeo mogamulizumab: Preliminary Phase II data

Preliminary data from an open-label, international Phase II trial in 71 patients with relapsed or refractory ATL showed that 1

Read the full 200 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE